CIK 0001580149 · Non-accelerated filer<br>Smaller reporting company
BIOVIE INC.
Sign in to watch- Ticker
- BIVI
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Jun 30
- Incorporated
- NV
- Entity type
- operating
- EIN
- 462510769
- Phone
- 775-888-3162
- Business address
- 680 W NYE LANE, SUITE 201, CARSON CITY, NV, 89703
- Former names
- NANOANTIBIOTICS, INC.
Securities
- BIVI Common stock Nasdaq
- BIVIW Warrant Nasdaq
- PRE 14A Proxy Proxy Statement (Preliminary)
- 8-K Event Other events
- 8-K/A Event Shareholder rights changed · Bylaws or fiscal year change
- 8-K Event Shareholder rights changed · Bylaws or fiscal year change · Shareholder vote results
- 8-K Event Executive or director change
- 4 Shares withheld for taxes Chief Medical Officer gave up 33,952 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Financial Officer gave up 23,202 shares (to pay taxes)
- 4 Shares withheld for taxes President & CEO gave up 51,906 shares (to pay taxes)
- SC 13D/A Stake Beneficial Ownership Report
- DEF 14A Proxy Proxy Statement
- PRE 14A Proxy Proxy Statement (Preliminary)
- 10-Q Report Quarterly Report
- 8-K Event Delisting notice
- UPLOAD Other SEC-generated Letter
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
- 8-K Event Other events
- 4 Open-market buy President & CEO bought 10,000 shares
- 8-K Event Regulation FD disclosure · Other events
- 8-K/A Event Exhibits
Page 7 of 26 · 511 filings